Rare disease focus Mendelian concentrates on helping clinicians identify undiagnosed rare diseases, presenting an opportunity to position solutions as essential support for GPs and specialists who manage complex, low-incidence cases.

Public funding leverage With prior government grants and Innovate UK funding, there is a track record of public-sector validation, suggesting potential for co-development, pilots, and grant-backed collaborations with NHS entities.

Growth through healthcare partners Existing pilot collaborations with regional NHS networks indicate openness to partnerships; selling into regional health ecosystems and AHSNs could accelerate adoption at scale.

Tech stack fit The platform likely leverages scalable cloud and search technologies (Elasticsearch, Kubernetes, EKS) suitable for secure patient data workflows, enabling conversations about interoperability and data governance with healthcare IT teams.

Financial upside With revenue in the low millions and modest funding, Mendelian is positioned for targeted enterprise deals at GP practices or regional health systems, offering a path from pilot to broader deployment as outcomes and ROI are demonstrated.